GoHealth (GOCO) Fundamental Analysis: Revenue, Earnings & Valuation

4.71 / 10

Netural

Fundamental analysis rates GOCO as neutral (4.7/10). Revenue‑MV and fixed‑asset turnover are strengths, while Asset‑MV and cash growth lag. Ratios such as current (1.64) and interest coverage (15.6) are solid, but overall metrics remain mixed.

Analysis Checks(8/10)

Revenue-MV

Value0.43

Score2/3

Weight6.19%

1M Return1.31%

Net profit attributable to parent company shareholders / Net profit (%)

Value51.73

Score2/3

Weight12.77%

1M Return2.45%

Accounts receivable turnover ratio

Value156.81

Score2/3

Weight-14.95%

1M Return-7.68%

Cash-UP

Value-0.01

Score1/3

Weight2.25%

1M Return0.57%

Fixed assets turnover ratio

Value10.86

Score3/3

Weight12.23%

1M Return2.46%

Interest coverage ratio (EBIT / Interest expense) (%)

Value15.64

Score2/3

Weight12.08%

1M Return2.44%

Diluted earnings per share (YoY growth rate %)

Value-509.55

Score3/3

Weight25.25%

1M Return4.62%

Asset-MV

Value-0.48

Score1/3

Weight11.56%

1M Return2.17%

Net profit attributable to parent company shareholders (YoY growth rate %)

Value-629.96

Score2/3

Weight20.02%

1M Return3.66%

Current ratio

Value1.64

Score3/3

Weight12.59%

1M Return2.53%

Is GOCO fundamentally strong?

GOCO scores 4.71/10 on fundamentals and holds a Fair valuation at present. Backed by its -89.66% ROE, -51.70% net margin, -0.28 P/E ratio, 1.15 P/B ratio, and -406.38% earnings growth, these metrics solidify its Netural investment rating.